Cytosorbents News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.11.24	Ausblick: Cytosorbents verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
23.10.24	Erste Schätzungen: Cytosorbents stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
01.10.24	CytoSorbents Announces DrugSorb-ATR De Novo Submission To FDA - Quick Facts (RTTNews)
12.08.24	Ausblick: Cytosorbents öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
30.07.24	CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website (GlobeNewswire)
13.06.24	CytoSorbents Announces Immediate Availability Of PuriFi Blood Pump In EU (RTTNews)
08.05.24	Ausblick: Cytosorbents legt Zahlen zum jüngsten Quartal vor (finanzen.net)
13.03.24	Ausblick: Cytosorbents gewährt Anlegern Blick in die Bücher (finanzen.net)
28.12.23	CytoSorbents: DrugSorb-ATR Study Fails To Meet Primary Effectiveness Endpoint (RTTNews)
08.11.23	Ausblick: Cytosorbents präsentiert Quartalsergebnisse (finanzen.net)
19.09.23	CytoSorbents Announces Reappointment Of Kathleen Bloch As Full-time CFO (RTTNews)
14.08.23	CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial (PR Newswire)
31.07.23	Ausblick: Cytosorbents stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
19.07.23	Cytosorbents Appoints Alexander D'Amico New CFO (RTTNews)
01.05.23	Ausblick: Cytosorbents verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
08.03.23	Ausblick: Cytosorbents präsentiert Quartalsergebnisse (finanzen.net)
27.02.23	CytoSorbents to Present at the Cowen 43rd Annual Health Care Conference (PR Newswire)
24.02.23	CytoSorbents to Report Fiscal 2022 Operating and Financial Results (PR Newswire)
22.02.23	Erste Schätzungen: Cytosorbents legt Zahlen zum jüngsten Quartal vor (finanzen.net)
31.01.23	CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue (PR Newswire)
23.01.23	CytoSorbents Announces Health Canada Regulatory Approval For Pivotal STAR-T Trial (PR Newswire)
17.01.23	CytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice President of Global Regulatory Affairs (PR Newswire)
29.12.22	CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement (PR Newswire)
21.12.22	CytoSorbents : DSMB Recommends To Continue Pivotal STAR-T Trial Without Any Modifications (RTTNews)
21.12.22	CytoSorbents Receives Recommendation from Independent Data and Safety Monitoring Board to Continue Pivotal STAR-T Trial As Planned Without Modifications (PR Newswire)
14.11.22	CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled (PR Newswire)
03.11.22	CytoSorbents Reports Third Quarter 2022 Financial and Operational Results (PR Newswire)
02.11.22	'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals (PR Newswire)
02.11.22	Ausblick: Cytosorbents vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
31.10.22	National Institutes of Health Grants Phase I SBIR Award to CytoSorbents to Test Novel Polymers for Cytokine and Endotoxin Removal from Septic Porcine Plasma (PR Newswire)
27.10.22	CytoSorbents to Report Third Quarter 2022 Operating and Financial Results (PR Newswire)
12.10.22	CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting (PR Newswire)
07.10.22	CytoSorbents Says CFO Kathleen Bloch Plans To Retire In March 2023 (RTTNews)
07.10.22	CytoSorbents Announces Pending Retirement of Chief Financial Officer Kathleen P. Bloch (PR Newswire)
06.10.22	CytoSorbents Awarded an Approximately $4.3M Contract by the U.S. Department of Defense to Develop HemoDefend-BGA™ for Freeze-Dried Universal Plasma (PR Newswire)
04.10.22	CytoSorbents to Present at the Dawson James Securities 2022 Small Cap Growth Conference (PR Newswire)
27.09.22	CytoSorbents Achieves ISO 13485 Certification of Princeton Manufacturing Facility in New Jersey (PR Newswire)
09.09.22	The U.S. Department of Defense Awards CytoSorbents an Approximately $2.0M Contract to Support HemoDefend-BGA™ Development for Life-saving Universal Plasma (PR Newswire)
07.09.22	CytoSorbents to Present at the H.C. Wainwright 24th Annual Global Investment Conference (PR Newswire)
23.08.22	Turkish Ministry of Health Grants National Reimbursement to CytoSorb® (PR Newswire)
17.08.22	Israeli Ministry of Health Approves National Coverage for CytoSorb® (PR Newswire)
02.08.22	CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms (PR Newswire)
02.08.22	CytoSorbents Reports Second Quarter 2022 Financial and Operational Results (PR Newswire)
01.08.22	Ausblick: Cytosorbents präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
25.07.22	CytoSorbents to Report Second Quarter 2022 Operating and Financial Results (PR Newswire)
08.07.22	The 2022 CytoSorb World Users' Meeting Highlights the Broad Market Potential of CytoSorb as an Interdisciplinary Therapeutic Approach (PR Newswire)
01.07.22	Leading Critical Care and Cardiac Surgery Specialists from 40 Countries Meet to Discuss CytoSorb and the New Dimension in Blood Purification (PR Newswire)
02.06.22	CytoSorbents to Hold 2022 Annual Meeting of Stockholders Virtually (PR Newswire)
01.06.22	CytoSorbents Partners with Nikkiso to Distribute the PureADJUST Hemoperfusion Blood Pump and Supplies in 14 Countries (PR Newswire)
19.05.22	CytoSorbents to Present at Two Upcoming Investor Conferences (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Cytosorbents Corp

Aktien Top/Flop

Meistgelesene Nachrichten